108 related articles for article (PubMed ID: 17452134)
1. AMPD1 gene polymorphism and survival in patients with stable congestive heart failure.
Palmer BR; Frampton CM; Richards AM; Cameron VA
Am Heart J; 2007 May; 153(5):e13. PubMed ID: 17452134
[No Abstract] [Full Text] [Related]
2. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
de Groote P; Mouquet F; Dallongeville J; Lamblin N; Bauters C
Am Heart J; 2007 May; 153(5):e15. PubMed ID: 17452135
[No Abstract] [Full Text] [Related]
3. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
[TBL] [Abstract][Full Text] [Related]
4. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
[TBL] [Abstract][Full Text] [Related]
6. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
Kolek MJ; Carlquist JF; Thaneemit-Chen S; Lazzeroni LC; Whiting BM; Horne BD; Muhlestein JB; Lavori P; Anderson JL
J Card Fail; 2005 Dec; 11(9):677-83. PubMed ID: 16360962
[TBL] [Abstract][Full Text] [Related]
7. Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
Yuen AH; Yacoub MH; Birks EJ; Kalsi KK; Johnson PH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):275-7. PubMed ID: 16021915
[TBL] [Abstract][Full Text] [Related]
8. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
Loh E; Rebbeck TR; Mahoney PD; DeNofrio D; Swain JL; Holmes EW
Circulation; 1999 Mar; 99(11):1422-5. PubMed ID: 10086964
[TBL] [Abstract][Full Text] [Related]
9. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism of the gene encoding AMPD1: clinical impact and proposed mechanisms in congestive heart failure.
Binkley PF; Auseon A; Cooke G
Congest Heart Fail; 2004; 10(6):274-78; quiz 279-80. PubMed ID: 15591841
[TBL] [Abstract][Full Text] [Related]
11. AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
Feldman AM; Wagner DR; McNamara DM
Circulation; 1999 Mar; 99(11):1397-9. PubMed ID: 10086958
[No Abstract] [Full Text] [Related]
12. Impact of genetic polymorphisms on heart failure prognosis.
Le Corvoisier P; Park HY; Carlson KM; Donahue MP; Marchuk DA; Rockman HA
Arch Mal Coeur Vaiss; 2003 Mar; 96(3):197-206. PubMed ID: 12722550
[TBL] [Abstract][Full Text] [Related]
13. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Safranow K; Suchy J; Jakubowska K; Olszewska M; Bińczak-Kuleta A; Kurzawski G; Rzeuski R; Czyżycka E; Łoniewska B; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
J Appl Genet; 2011 Feb; 52(1):67-76. PubMed ID: 21108053
[TBL] [Abstract][Full Text] [Related]
14. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis.
Feng AF; Liu ZH; Zhou SL; Zhao SY; Zhu YX; Wang HX
BMC Cardiovasc Disord; 2017 Jul; 17(1):174. PubMed ID: 28673246
[TBL] [Abstract][Full Text] [Related]
15. Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation.
Rybakowska I; Bakuła S; Klimek J; Milczarek R; Smolenski RT; Kaletha K
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):453-6. PubMed ID: 20544536
[TBL] [Abstract][Full Text] [Related]
16. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
[TBL] [Abstract][Full Text] [Related]
18. Relation between AT1R gene polymorphism and long-term outcome in patients with heart failure.
Amir O; Amir RE; Paz H; Attias E; Sagiv M; Lewis BS
Cardiology; 2009; 112(2):151-7. PubMed ID: 18612202
[TBL] [Abstract][Full Text] [Related]
19. Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure.
Pop D; Zdrenghea D; Procociuc LM; Popal A
Rom J Intern Med; 2007; 45(4):349-54. PubMed ID: 18767410
[TBL] [Abstract][Full Text] [Related]
20. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
